by EmpathiCSubstanceS | Apr 20, 2022 | Cancer, Iboga, Kambo, LSD, Parkinson's Disease, Psilocybin Magic Mushroom, Psychotropics, PTSD
Adults who have at some time in their life used psilocybin – a psychedelic substance produced by some types of mushrooms – are 30% less likely to have opioid use disorder, according to a nationally representative survey of US adults reported in the journal Scientific...
by EmpathiCSubstanceS | Apr 20, 2022 | Cancer, Neuropathy, NN-Dimethyltryptamine, OCD, Pain, Parkinson's Disease, Psilocybin Magic Mushroom, Psychotropics, PTSD, San Pedro Mescaline
Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the...
by EmpathiCSubstanceS | Apr 20, 2022 | Ayahuasca, Cancer, CBC, Iboga, Pain, Psilocybin Magic Mushroom, San Pedro Mescaline
Psilocybin, the psychedelic compound found in magic mushrooms, helps to “open up” depressed people’s brains, even after use, enabling brain regions to talk more freely to one another. These are the findings of a new analysis of brain scans from close to 60 people...
by EmpathiCSubstanceS | Feb 2, 2022 | Neuropathy, OCD, Pain, Parkinson's Disease, Psilocybin Magic Mushroom, Psychotropics, San Pedro Mescaline
The psychedelic state is unquestionably one of the most interesting psychological experiences humans can have. Hallucinogenic drugs that have been used by humans for as long as we can determine to provide novel insights into the mind and enhance social bonding. For...
by EmpathiCSubstanceS | Feb 2, 2022 | Cannabis Marijuana, Iboga, Kambo, LSD, Microdosing, Neuropathy, NN-Dimethyltryptamine, Pain, Parkinson's Disease, Psilocybin Magic Mushroom, Psychotropics, PTSD, San Pedro Mescaline
This question can be approached from a number of different levels. At the lowest functionally relevant level, how do the hallucinogenic compounds themselves interact with a certain neurotransmitter receptor to alter neuronal activity? Then at the neuronal population...
